Adimmune Corporation (TPE:4142)

Adimmune Revenue

Adimmune had revenue of 66.76M TWD in the quarter ending June 30, 2026, a decrease of -38.54%. This brings the company's total for the last twelve months to 1.37B, down -15.13% year-over-year. In the year 2025, Adimmune had annual revenue of 1.40B, down -9.99%. That makes Adimmune the 29,169th largest company in the world by revenue and 1,406th in Taiwan.

• Revenue (ttm): 1.37B
• Revenue Growth: -15.13%
• P/S Ratio: 5.48
• Revenue / Employee: 2.43M
• Employees: 564
• Market Cap: 7.50B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Adimmune Corporation 1.40B 96.7%
• Enimmune Corporation 48.20M 3.3%

By Geography

Chart

• Taiwan 782.61M 55.8%
• USA 415.54M 29.6%
• China 123.82M 8.8%
• Other 79.53M 5.7%

Fiscal year ended Dec 31, 2025 See the full Adimmune breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.40B	-155.49M	-9.99%
Dec 31, 2024	1.56B	-228.11M	-12.78%
Dec 31, 2023	1.79B	-466.53M	-20.72%
Dec 31, 2022	2.25B	457.85M	25.52%
Dec 31, 2021	1.79B	-75.37M	-4.03%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 17, 2026

Data Sources Report a data error